Abstract
Characterization of the stability of analytes in biological samples collected during clinical studies together with that of critical assay reagents, including analyte stock solutions, is recognized as an important component of bioanalytical assay validation. Deficiencies in these areas often come to light during regulatory inspections. Best practices, based on current regulatory guidance, for the assessment of these issues as they pertain to ligand binding and chromatographic assays are covered in this review. Additionally, consensus recommendations reached during the recent AAPS/FDA Workshop on bioanalytical assay validation are highlighted.
Keywords: Stability, biological samples, test article, bioanalytical, ligand binding assay, chromatographic assay
Full Text
The Full Text of this article is available as a PDF (538.1 KB).
References
- 1.US Department of Health and Human Services, FDA, CDER, CVM . Guidance for the Industry: Bioanalytical Method Validation. Washington, DC: US Department of health and Human Services, FDA, CDER and CVM; 2001. [Google Scholar]
- 2.Shah VP, Midha KK, Findlay JWA, et al. Bioanalytical method validation—a revisit with a decade of progress. Pharm Res. 2000;17:1551–1557. doi: 10.1023/A:1007669411738. [DOI] [PubMed] [Google Scholar]
- 3.DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003;20:1885–1900. doi: 10.1023/B:PHAM.0000003390.51761.3d. [DOI] [PubMed] [Google Scholar]
- 4.Viswanathan CT, Bansal S, Booth B, et al. Workshop/conference report—quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J [serial online] 2007;9:E30–E42. doi: 10.1208/aapsj0901004. [DOI] [PubMed] [Google Scholar]
- 5.Yau M. Stability of samples, standards, QC's, and reagent: FDA perspective. Quantitative bioanalytical methods validation and implementation—best practices for chromatographic and ligand binding assays. Paper presented at the AAPS/FDA Workshop, May 2, 2006, Arlington, VA.